A treatment with Fulvestrant and Exemestane in postmenopausal patients with advanced hormone receptor–positive (HR) + breast cancer - ACT-FASTER:

Study identifier:NIS-ODE-FAS-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An epidemiological prospective Cohort study to describe Treatment patterns of Fulvestrant And ExemeSTane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in GERmany

Medical condition

postmenopause

Phase

-

Healthy volunteers

No

Study drug

-

Sex

Female

Actual Enrollment

570

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Aug 2010
Primary Completion Date: 01 Nov 2013
Study Completion Date: 01 Nov 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria